Polaris Venture Management Co. V as of June 30, 2016
Portfolio Holdings for Polaris Venture Management Co. V
Polaris Venture Management Co. V holds 10 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Selecta Biosciences (RNAC) | 28.9 | $27M | 1.9M | 13.99 | |
| T2 Biosystems | 15.9 | $15M | 1.9M | 7.89 | |
| Trevena | 15.3 | $14M | 2.3M | 6.30 | |
| Genocea Biosciences | 8.7 | $8.1M | 2.0M | 4.10 | |
| Pulmatrix | 7.6 | $7.1M | 3.6M | 1.96 | |
| Cerulean Pharma | 7.5 | $7.0M | 3.3M | 2.12 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 5.5 | $5.1M | 1.8M | 2.78 | |
| Ocular Therapeutix (OCUL) | 5.3 | $4.9M | 999k | 4.95 | |
| Fate Therapeutics (FATE) | 4.5 | $4.2M | 2.5M | 1.70 | |
| Bind Therapeutics | 0.8 | $787k | 2.0M | 0.39 |
